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ABSTRACT
Yellow Fever (YF) remains a major public health issue in Sub-Saharan Africa and South America, despite the availability of
an eﬀective vaccine. In Africa, most YF outbreaks are reported in West Africa. However, urban outbreaks occurred in 2016
in both Angola and the Democratic Republic of Congo (DRC), and imported cases were reported in Chinese workers
coming back from Africa. In Central Africa, Cameroon and the Republic of Congo host a high proportion of non-
vaccinated populations increasing the risk of urban outbreaks. The main vector is Aedes aegypti and possibly, Aedes
albopictus, both being anthropophilic and domestic mosquitoes. Here, we provide evidence that both Ae. aegypti and
Ae. albopictus in Cameroon and the Republic of Congo are able to transmit Yellow fever virus (YFV) with higher rates
of infection, dissemination, and transmission for Ae. aegypti. We conclude that the potential of both Aedes species to
transmit YFV could increase the risk of urban YF transmission and urge public health authorities to intensify their
eﬀorts to control domestic vectors, and extend vaccine coverage to prevent major YFV outbreak.
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Background
Yellow fever (YF) is a mosquito borne viral disease
endemic in South America and Sub-Saharan African
countries. Clinical signs vary from a fever with aches
and pains to severe liver disease with bleeding and yel-
lowing skin (jaundice), for which there is no speciﬁc
treatment. Despite the availability of an eﬀective vac-
cine, which can oﬀer a lifelong immunity, numerous
cases of YF are still being reported. Indeed, a modelling
study based on African data sources estimated that the
burden of YF during 2013 was 84 000–170 000 severe
cases and 29 000–60 000 deaths [1]. Yellow fever
virus (YFV, Flavivirus, Flaviviridae) is transmitted to
humans and non-human primates mainly by bites of
infected mosquitoes belonging to Aedes and Haemago-
gus genera. This virus primarily circulates in the forest
between non-human primates and sylvatic Aedes spp.
mosquitoes (e.g. Ae. africanus) in Africa andHaemago-
gus spp. in South America [2]. Nevertheless, YF can
spread widely in urban environments when trans-
mitted from human to human by the anthropophilic
mosquitoes, Aedes aegypti [3] or potentially, Aedes
albopictus [4,5]. Indeed, between 2015 and 2016 in
Central Africa, major urban YF outbreaks occurred
in Angola and Democratic Republic of Congo with
7,334 suspected cases, of which 962 have been
conﬁrmed, and 393 deaths [6]. Aedes aegypti was sus-
pected as the main YFV vector involved during the
Angola outbreak due to its high densities reported
across the country [7]. On the other hand, recent
studies on entomological surveillance in Central Africa
particularly in Cameroon [8] and the Republic of
Congo [9], where sporadic cases of YF were frequently
reported, showed that Ae. aegypti is present in all urban
environments while Ae. albopictus introduced in 2000s
has a distribution limited under 6°N latitude. In sym-
patric areas, Ae. albopictus tends to be the most preva-
lent species by replacing the resident species Ae. aegypti
[8–10]. In Cameroon, the ﬁrst isolation of YFV was in
1990 during an outbreak with 180 cases, of which 125
fatalities [11]. The suspected mosquito vectors were Ae.
aegypti, Ae. furcifer, and Ae. luteocephalus. From 2010
to 2016, 13,837 suspected cases of YF were reported of
which 109 cases were conﬁrmed with 66% mostly in
rural areas [7]. The epidemiological importance of
both vectors in urban YFV transmission in Central
Africa has not been assessed precisely up to now. As
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the vector competence is one of the key parameters to
assess the pathogen transmission, we undertook a
study aimed at establishing the ability of Ae. aegypti
and Ae. albopictus populations collected in diﬀerent
urban settings in Central Africa to transmit YFV strain
isolated in West Africa.
Material and methods
Ethics statement
This study was approved by the Cameroonian national
ethics committee for human health research N˚2017/05/
911/CE/CNERSH/SP. Oral consent to inspect the
potential breeding sites was obtained in the ﬁeld in
household or garage owners. The Institut Pasteur ani-
mal facility received accreditation from the French
Ministry of Agriculture to perform experiments on
live animals in compliance with the French and Euro-
pean regulations on care and protection of laboratory
animals (EC Directive 2010/63, French Law 2013-
118, 6 February 2013). All experiments were approved
by the Ethics Committee and registered under the
reference APAFIS6573-201606l412077987 v2.
Mosquito sampling
Larvae and pupae were collected from August 2017 to
April 2018 in several locations in Central Africa includ-
ing the Republic of Congo (Brazzaville) and Cameroon
(Yaoundé, Douala, Tibati and Bénoué National Park).
Each of these locations has been previously described
[8,9] except Bénoué National Park (8°20′N, 13°50′E);
it is a biosphere reserve located in Northern part of
Cameroon on the Bénoué River plain, at the foot of
the Adamawa plateau. In Benoué park, Aedes larvae
were collected across the park in tree holes (1), tin
cans (15), used tires (2) and discarded chair (1). For
other locations, mosquitoes were collected in peri-
urban and downtown in a minimum of 20 containers
per environment. Immature stages of Aedes were trans-
ported in the insectary and pooled together according
to the city and raised until adults before morphological
identiﬁcation using criteria established by Jupp (1996)
[12]. Adult mosquitoes were pooled together according
to the location, species and reared at 28°±1°C under
12 h dark:12 h light cycle and 80% relative humidity.
Eggs obtained (Table 1) were transported to the Institut
Pasteur in Paris, reared to adult stage and used to chal-
lenge with YFV.
Virus strain
YFV was isolated from a human case in Senegal in 1979
(YFV S79; accession number: MK060080) [13]. YFV
S79 was passaged twice on newborn mice and two
times on C6/36 cells. Viral stocks were produced on
Aedes albopictus C6/36 cells.
Challenge mosquitoes with YFV
For each population, six batches of 60 7–10 day-old
females were challenged with an infectious blood
meal containing 1.4 mL of washed rabbit erythrocytes
and 700 μL of viral suspension. The blood meal was
supplemented with adenosine 5’-triphosphate (ATP)
as a phagostimulant at a ﬁnal concentration of 1 mM
and provided to mosquitoes at a titer of 107 focus-
forming unit (FFU)/mL using a Hemotek membrane
feeding system (Hemotek Ltd, Blackburn, UK). Mos-
quitoes were allowed to feed for 20 min through a
piece of pork intestine covering the base of a Hemotek
feeder maintained at 37°C. Fully engorged females were
transferred in cardboard containers and maintained
with 10% sucrose under controlled conditions (28±1°
C, relative humidity of 80%, light:dark cycle of
12h:12 h) for up to 21 days with mosquito analysed
at 14 and 21 days post-infection (dpi). 21–32 mosqui-
toes were examined at each dpi.
Infection, dissemination and transmission
assays
For each mosquito examined, body (abdomen and
thorax) and head were tested respectively for infection
and dissemination rates at 14 and 21 dpi per popu-
lation when the number permitted. For this, each
part was ground individually in 300 μL of L15 medium
(Invitrogen, CA, USA) supplemented with 2% fetal
serum bovine (FBS), and centrifuged at 10,000×g for
5 min at +4°C. The supernatant was processed for
viral titration. Saliva was collected from individual
mosquitoes at 21 dpi using the forced salivation tech-
nique as described previously [14]. Brieﬂy, mosquitoes
were cool anesthetized, wings and legs of each mos-
quito were removed and the proboscis inserted into a
tip of 20 µL containing 5 µL of FBS. After 30 min,
FBS containing saliva was added to 45 µL of L15 med-
ium for titration. Transmission rates were assessed
only at 21 dpi based on previous studies demonstrated
that higher transmission rates were reported at this
time point [15].
Table 1. Origin of Ae. aegypti and Ae. albopictus used for
vector competence.
Location Species Generation
Yaoundé Ae. albopictus G2
Tibati Ae.albopictus G2
Douala Ae. albopictus G2
Brazzaville Ae. albopictus G5
Yaoundé Ae. aegypti G2
Bénoué Parc Ae. aegypti G4
Brazzaville Ae. aegypti G2
Douala Ae. aegypti G2
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Infection rate (IR) refers to the proportion of mos-
quitoes with infected body (i.e. abdomen and thorax)
among tested mosquitoes. Disseminated infection
rate (DIR) corresponds to the proportion of mosqui-
toes with infected head among the previously detected
infected mosquitoes (i.e. virus positive abdomen/
thorax). Transmission rate (TR) represents the pro-
portion of mosquitoes with infectious saliva among
mosquitoes with disseminated infection. Vector com-
petence can be summarized by the transmission
eﬃciency (TE) which was calculated as the proportion
of mosquitoes with infectious saliva among all mosqui-
toes tested [16].
Viral titration by focus forming assay
Samples were titrated by focus ﬂuorescent assay on
C6/36 Ae. albopictus cells [17]. Body, head and saliva
suspensions were serially diluted in L15 medium sup-
plemented with 2% of FBS and inoculated onto cells
in 96-well plates. After an incubation of 5 days at 28°
C, samples were ﬁxed with 0.1 mL/well of formal-
dehyde 3.6% in phosphate buﬀer saline (PBS) during
20 min at room temperature. Then, plates were
stained using antibodies speciﬁc to YFV (Bio-techne,
Minneapolis, Minnesota, USA) as the primary anti-
body and conjugated Alexa Fluor 488 goat anti-
mouse IgG as the second antibody (Life Technol-
ogies, California, USA). Titers were expressed as
FFU/mL.
Statistical analysis
All statistical analyses were performed with R software
v 3.5.2 (R Core Team, Vienna, Austria). Qualitative
variables were expressed as proportion and compared
using Fisher’s exact test the RVAideMemoire package
and quantitative variables by mean and compared
using non-parametric test of Kruskal–Wallis because
of non-normal distribution. P-value <0.05 was con-
sidered as statistically diﬀerent.
Results
Infection and disseminated infection rates in Ae.
albopictus and Ae. aegypti
Mosquitoes were analysed at two time points follow-
ing the infectious blood meal when the number of
mosquitoes was suﬃcient: 14 and 21 days post infec-
tion (dpi) (Figures 1 and 2). At 14 dpi, no signiﬁcant
diﬀerence of infection rate (IR) and disseminated
infection rate (DIR) was found between Ae. albopic-
tus populations, respectively P = 0.89 and P = 0.18
(Fisher’s exact test) (Figure 1A). Besides, in Ae.
aegypti, IRs were signiﬁcantly diﬀerent (Fisher’s
exact test: P=0.01) ranging from 37.5% in Yaoundé
to 79.2% in Brazzaville (Figure 2A) while DIRs
were not signiﬁcantly diﬀerent (Fisher’s exact test:
P = 0.49). When considering all populations of same
species, IRs for Ae. aegypti (mean = 54.9%) was sig-
niﬁcantly higher than Ae. albopictus (mean = 30.7%)
(Fisher’s exact test: P = 0.02) while DIRs were not sig-
niﬁcantly diﬀerent (Ae. aegypti: mean = 56.8% and
Ae. albopictus: mean = 54.5%). At 21 dpi, IRs for
Ae. albopictus ranged from 16.8% in Douala to
54.5% in Tibati and were not statistically diﬀerent
(Figure 1B; Fisher’s exact test: P=0.08). In Ae. albo-
pictus, DIRs ranged from 0 for Douala population
suggesting no dissemination to 55% in Brazzaville
Figure 1. Infection, disseminated infection, transmission rates and transmission eﬃciency of Ae. albopictus from Central Africa to
yellow fever virus. (A) Infection and disseminated infection rates at 14 days post-infection (dpi). (B) Infection, disseminated infection,
transmission rates and transmission eﬃciency at 21 dpi. Error bars show the 95% conﬁdence interval. In brackets, the number of
mosquitoes examined. IR: the proportion of mosquitoes with infected body among engorged mosquitoes; DIR: the proportion of
mosquitoes with infected head among mosquitoes with infected body; TR: the proportion of mosquitoes with infectious saliva
among mosquitoes with infected head. TE: the proportion of mosquitoes with infectious saliva among all analysed ones.
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population. Meanwhile, for three populations where
viral dissemination was reported, no statistical diﬀer-
ence was found (Figure 1B; Fisher’s exact test: P =
0.34). In Ae. aegypti, IRs varied between 31.2%
(Douala) and 66.7% (Bénoué, Brazzaville) and were
not statistically diﬀerent (Fisher’s exact test: P =
0.11). DIRs were not signiﬁcantly diﬀerent (Fisher’s
exact test: P = 0.14) ranging from 40% (Douala) to
81.2% (Brazzaville) (Figure 2B). Overall, at 21 dpi,
IRs were higher for Ae. aegypti (54.5%) than for
Ae. albopictus (16.7%) (Fisher’s exact test: P = 0.005)
while for DIRs, no signiﬁcant diﬀerence was reported
between both species (Fisher’s exact test: P > 0.5).
When considering the two mosquito species from a
same location, IRs and DIRs were not signiﬁcantly
diﬀerent (Fisher’s exact test: P > 0.05) except for IRs
of Ae. aegypti and Ae. albopictus from Brazzaville at
14 dpi (P = 0.013).
Transmission rate and transmission
eﬃciency
Our analysis showed that YFV was able to replicate,
disseminate and be excreted in saliva of both Ae. albo-
pictus and Ae. aegypti (Figures 1B and 2B).However, in
Ae. albopictus, YFV was detected only in saliva of Braz-
zaville population. In contrast, in Ae. aegypti, YFV was
found in saliva of all tested populations with trans-
mission rate (TR) and transmission eﬃciency (TE)
ranging from 11.1% (Yaoundé) to 50% (Douala) and
3.2% (Yaoundé) to 25% (Brazzaville) respectively. Col-
lectively, Ae. aegypti exhibited a higher TE (10.4%)
than Ae. albopictus populations (2.2%) (Fisher’s exact
test: P = 0.03). In Ae. aegypti, viral titers varied signiﬁ-
cantly from Yaoundé population to Brazzaville
population (Figure 2; Chi-squared = 7.91; df = 3; P =
0.04). In Ae. albopictus Brazzaville population, viral
load in saliva was higher than in some Ae. aegypti
populations (Figure 3).
Discussion
Yellow fever virus is circulating in Central Africa where
massive outbreaks have been reported recently in
Angola and the Democratic Republic of Congo [6] in
spite of the availability of an eﬀective vaccine. In this
study, we assessed the ability of Ae. aegypti and Ae.
albopictus collected in diﬀerent ecological settings in
Cameroon and the Republic of Congo to transmit
YFV isolated from a human case in Senegal. Our analy-
sis showed that YFV was able to replicate, disseminate
and be excreted in saliva of both Ae. aegypti and Ae.
albopictus from Central Africa at 21 dpi. High levels
of infection and disseminated infection rates were
reported in both species from diﬀerent locations.
YFV was only detected in saliva of a single population
of Ae. albopictus from Brazzaville (Congo) at 21 dpi
with a transmission rate comparable to that found for
Ae. albopictus populations from South France and
Morocco [4,18], suggesting a low potential of this
species to sustain an active viral transmission. Further-
more, YFV was found at 21 dpi in saliva of all popu-
lations of Ae. aegypti from diﬀerent ecological
settings, indicating a higher epidemiological risk
related to this mosquito in urban areas. Interestingly,
transmission rate reported in Ae. aegypti populations
was similar to those reported in previous studies
undertaken in Carbo Verde [19], Brazil [20] and Gua-
deloupe [15] using the same YFV strain (Senegal 1979).
The unique Ae. albopictus population in which virus
Figure 2. Infection, disseminated infection, transmission rates and transmission eﬃciency of Ae. aegypti from Central Africa to yel-
low fever virus. (A) Infection and disseminated infection rates at 14 days post-infection (dpi). (B) Infection, disseminated infection,
transmission rates and transmission eﬃciency at 21 dpi. Error bars show the 95% conﬁdence interval. In brackets, the number of
mosquitoes examined. IR: the proportion of mosquitoes with infected body among engorged mosquitoes; DIR: the proportion of
mosquitoes with infected head among mosquitoes with infected body; TR: the proportion of mosquitoes with infectious saliva
among mosquitoes with infected head. TE: the proportion of mosquitoes with infectious saliva among all analysed ones.
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was detected has a higher viral load than many other
Ae. aegypti populations tested suggesting that in
some areas, Ae. albopictus could intervene in YFV
transmission. This result is quite alarming since Ae.
albopictus has been found most prevalent in some
rural [21], urban and peri-urban environments [8–
10] in Central Africa. Interestingly, Ae. albopictus has
been found naturally infected by YFV in Brazil and
could serve as bridge vector for transferring enzootic
YFV at the urban-forest/rural interface in Central
Africa into cities as suggested previously in Brazil
[22]. However, other factors should be considered to
determine if a mosquito species can act as a vector
under natural conditions: mosquito lifespan, trophic
preferences or vector abundance [23]. Likewise, bac-
terial symbionts of mosquitoes have been shown to
alter the vector competence to arboviruses
[24]; Ae. albopictus from Brazzaville might have under-
gone changes in bacteria composition as the 5th gener-
ation in the laboratory was used for experimental
infections.
Our experiment is the ﬁrst one establishing the vec-
tor competence of Ae. aegypti and Ae. albopictus
towards YFV in Central Africa. We showed that Ae.
albopictus in a populated city like Brazzaville, can
experimentally transmit YFV at 21 dpi suggesting a
potential of this species to participate in YFV trans-
mission but perhaps too late to pose an immediate
threat for the region. However, YFV can evolve by
becoming more adapted for a higher transmission by
an unusual vector species [5]. Further studies using a
local strain of YFV circulating in Central Africa are
needed to validate these results. Our ﬁndings support
the eﬀorts needed in vector surveillance and control,
and vaccine coverage to prevent major YFV outbreak
as reported recently in Angola.
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